Latest Drug Approvals news
FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
posted May 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Delays Final Approval of Novavax COVID Vaccine
posted April 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
posted April 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Related Articles
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children 
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries 
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy Monthly Specialist Briefings
Stay Connected
